Skip to main content

Knott David M Jr

13F filer · CIK 0001892770
Reported Aug 12, 2026
Net seller this quarter
13F portfolio value$189MU.S. long equity reported on 13F
Positions769 new · 11 closed
Net flow last quarter-$3.86MBuys minus sells
Top 10 positions weight62.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 12, 202676 positions
GOOGAlphabet Inc.$32.3M17.07%Not reportedNot reportedQ4 2021
APOApollo Global Management, Inc.$26.6M14.07%0.04%Not reportedQ4 2021
SNDXSyndax Pharmaceuticals Inc$9.56M5.05%0.49%+3.6%Q1 2024
XERSXeris Biopharma Holdings, Inc.$8.4M4.44%0.61%Not reportedQ4 2023
TVTXTravere Therapeutics, Inc.$8.37M4.42%0.16%+4.7%Q3 2023
PTGXProtagonist Therapeutics, Inc$7.72M4.08%0.10%Not reportedQ3 2023
BBIOBridgeBio Pharma, Inc.$6.92M3.66%0.05%+3.2%Q1 2022
IOVAIovance Biotherapeutics, Inc.$6.66M3.52%0.35%Not reportedQ4 2021
ALKSAlkermes plc.$6.38M3.37%0.07%+1.5%Q2 2023
JPMJPMorgan Chase & Co$5.92M3.13%0.00%-7.1%Q4 2021
COGTCogent Biosciences, Inc.$4.3M2.27%0.06%+6.8%Q1 2025
TGTXTG Therapeutics, Inc.$3.67M1.94%0.04%-25.7%Q4 2021
CLSTCatalyst Bancorp, Inc.$3.58M1.89%2.83%NewQ2 2026
AGIOAgios Pharmaceuticals, Inc.$3.53M1.86%0.16%+2.2%Q4 2025
VRDNViridian Therapeutics, Inc.\DE$3.32M1.76%0.16%Not reportedQ4 2024
RLMDRelmada Therapeutics, Inc.$3.12M1.65%0.42%+2.7%Q4 2021
RCUSArcus Biosciences, Inc.$2.5M1.32%0.06%Not reportedQ1 2025
HELPCybin Inc.$2.45M1.29%0.72%+5.7%Q4 2024
RZLTRezolute, Inc.$1.92M1.02%0.38%Not reportedQ3 2025
ABAlliancebernstein Holding L.P.$1.69M0.89%0.05%Not reportedQ4 2021
MDGLMadrigal Pharmaceuticals, Inc.$1.61M0.85%0.01%+50.0%Q3 2022
ATRCAtriCure, Inc.$1.44M0.76%0.10%Not reportedQ1 2025
DCGODocGo Inc.$1.38M0.73%2.70%Not reportedQ4 2021
ARDXArdelyx, Inc.$1.34M0.71%0.11%+27.1%Q3 2022
RAREUltragenyx Pharmaceutical Inc.$1.27M0.67%0.04%+15.1%Q1 2025
CGEMCullinan Therapeutics, Inc.$1.26M0.67%0.11%+185.9%Q1 2026
JNJJohnson & Johnson$1.25M0.66%0.00%Not reportedQ4 2021
VERAVera Therapeutics, Inc.$1.12M0.59%0.04%Not reportedQ1 2025
OBIOOrchestra BioMed Holdings, Inc.$1.09M0.58%0.42%Not reportedQ2 2025
SPRBSpruce Biosciences, Inc.$1.08M0.57%0.73%NewQ2 2026
CNTBConnect Biopharma Holdings Ltd$1.06M0.56%0.71%+14.7%Q4 2025
BIIBBiogen Inc.$864K0.46%0.00%Not reportedQ3 2025
PFEPfizer Inc$779K0.41%0.00%Not reportedQ4 2021
AAPLApple Inc.$722K0.38%0.00%Not reportedQ4 2021
CNQCANADIAN NATURAL RESOURCES Ltd$664K0.35%0.00%Not reportedQ4 2021
PTHSPelthos Therapeutics Inc.$624K0.33%0.59%+4.8%Q3 2025
IBMInternational Business Machines Corp$602K0.32%0.00%Not reportedQ1 2023
MSFTMicrosoft Corp$597K0.32%0.00%Not reportedQ4 2021
VSTMVerastem, Inc.$592K0.31%0.17%+49.0%Q1 2026
KURAKura Oncology, Inc.$579K0.31%0.06%Not reportedQ2 2024
SLDBSolid Biosciences Inc.$562K0.30%0.05%+19.2%Q1 2025
INSMINSMED Inc$453K0.24%0.00%NewQ2 2026
LBRXLB Pharmaceuticals Inc$421K0.22%0.05%NewQ2 2026
CDNACareDx, Inc.$388K0.21%0.03%NewQ2 2026
QTTBQ32 Bio Inc.$387K0.20%0.13%NewQ2 2026
ELVNEnliven Therapeutics, Inc.$314K0.17%0.01%NewQ2 2026
RHPRyman Hospitality Properties, Inc.$309K0.16%0.00%Not reportedQ4 2021
AVGOBroadcom Inc.$268K0.14%0.00%Not reportedQ2 2022
KMBKimberly Clark Corp$263K0.14%0.00%Not reportedQ4 2021
NVDANvidia Corp$256K0.14%0.00%Not reportedQ2 2022
Q1 2026Reported May 14, 202678 positions
GOOGAlphabet Inc.$26.2M15.61%Not reportedNot reportedQ4 2021
APOApollo Global Management, Inc.$25.1M14.92%0.04%Not reportedQ4 2021
SNDXSyndax Pharmaceuticals Inc$9.86M5.87%0.48%+1.7%Q1 2024
BBIOBridgeBio Pharma, Inc.$6.68M3.98%0.05%+5.9%Q1 2022
PTGXProtagonist Therapeutics, Inc$6.64M3.95%0.10%-13.7%Q3 2023
XERSXeris Biopharma Holdings, Inc.$6.15M3.66%0.61%+9.3%Q4 2023
JPMJPMorgan Chase & Co$5.73M3.41%0.00%Not reportedQ4 2021
IOVAIovance Biotherapeutics, Inc.$5.62M3.34%0.37%Not reportedQ4 2021
ALKSAlkermes plc.$4.24M2.53%0.07%+26.3%Q2 2023
TVTXTravere Therapeutics, Inc.$4.18M2.49%0.15%-24.4%Q3 2023
COGTCogent Biosciences, Inc.$4M2.38%0.06%+2.0%Q1 2025
VRDNViridian Therapeutics, Inc.\DE$3.54M2.11%0.18%+24.8%Q4 2024
AGIOAgios Pharmaceuticals, Inc.$3.15M1.87%0.16%+417.0%Q4 2025
RLMDRelmada Therapeutics, Inc.$3.06M1.82%0.42%Not reportedQ4 2021
TGTXTG Therapeutics, Inc.$2.99M1.78%0.06%+100.0%Q4 2021
CPRXCatalyst Pharmaceuticals, Inc.$2.97M1.77%0.10%-36.5%Q4 2023
ACLXArcellx, Inc.$2.23M1.33%0.03%-24.4%Q1 2023
ABAlliancebernstein Holding L.P.$1.8M1.07%0.05%Not reportedQ4 2021
RCUSArcus Biosciences, Inc.$1.75M1.04%0.06%-33.0%Q1 2025
DCGODocGo Inc.$1.68M1.00%2.70%Not reportedQ4 2021
HELPCybin Inc.$1.68M1.00%0.68%+22.7%Q4 2024
CYTKCytokinetics Inc$1.56M0.93%0.02%-30.5%Q1 2024
CNTACentessa Pharmaceuticals PLC$1.55M0.92%0.03%+875.0%Q4 2025
ATRCAtriCure, Inc.$1.47M0.87%0.10%Not reportedQ1 2025
ARDXArdelyx, Inc.$1.24M0.74%0.08%Not reportedQ3 2022
JNJJohnson & Johnson$1.2M0.72%0.00%-28.9%Q4 2021
RZLTRezolute, Inc.$1.13M0.67%0.38%+8.8%Q3 2025
OBIOOrchestra BioMed Holdings, Inc.$1.08M0.64%0.43%+1.5%Q2 2025
MDGLMadrigal Pharmaceuticals, Inc.$1.05M0.62%0.01%Not reportedQ3 2022
VERAVera Therapeutics, Inc.$1.05M0.62%0.04%Not reportedQ1 2025
CNTBConnect Biopharma Holdings Ltd$1.02M0.60%0.62%+93.9%Q4 2025
PFEPfizer Inc$908K0.54%0.00%Not reportedQ4 2021
BMYBristol Myers Squibb Co$826K0.49%0.00%-38.1%Q4 2021
CNQCANADIAN NATURAL RESOURCES Ltd$819K0.49%0.00%Not reportedQ4 2021
BIIBBiogen Inc.$733K0.44%0.00%-33.3%Q3 2025
RAREUltragenyx Pharmaceutical Inc.$693K0.41%0.03%+65.3%Q1 2025
AAPLApple Inc.$633K0.38%0.00%Not reportedQ4 2021
MSFTMicrosoft Corp$592K0.35%0.00%Not reportedQ4 2021
VSTMVerastem, Inc.$551K0.33%0.12%NewQ1 2026
ADMAAdma Biologics, Inc.$542K0.32%0.03%Not reportedQ4 2021
IBMInternational Business Machines Corp$519K0.31%0.00%Not reportedQ1 2023
PTHSPelthos Therapeutics Inc.$443K0.26%0.63%+9.3%Q3 2025
KURAKura Oncology, Inc.$429K0.26%0.06%+34.6%Q2 2024
EOLSEvolus, Inc.$408K0.24%0.15%Not reportedQ1 2023
CGEMCullinan Therapeutics, Inc.$344K0.20%0.04%NewQ1 2026
SLDBSolid Biosciences Inc.$339K0.20%0.05%-71.0%Q1 2025
LENZLENZ Therapeutics, Inc.$309K0.18%0.11%-37.2%Q2 2025
WVEWave Life Sciences, Inc.$290K0.17%0.02%-55.6%Q1 2025
RAINRain Enhancement Technologies Holdco, Inc.$258K0.15%Not reportedNewQ1 2026
KMBKimberly Clark Corp$232K0.14%0.00%Not reportedQ4 2021
Q4 2025Reported Feb 12, 202681 positions
CLMTCalumet, Inc.$44M20.38%2.55%-21.6%Q4 2021
APOApollo Global Management, Inc.$32.6M15.08%0.04%Not reportedQ4 2021
GOOGAlphabet Inc.$28.7M13.28%Not reported-18.5%Q4 2021
SNDXSyndax Pharmaceuticals Inc$8.72M4.04%0.47%-3.0%Q1 2024
XERSXeris Biopharma Holdings, Inc.$7.61M3.53%0.58%-4.4%Q4 2023
TVTXTravere Therapeutics, Inc.$7.11M3.29%0.20%-28.5%Q3 2023
BBIOBridgeBio Pharma, Inc.$6.5M3.01%0.04%Not reportedQ1 2022
PTGXProtagonist Therapeutics, Inc$6.38M2.95%0.12%-12.1%Q3 2023
JPMJPMorgan Chase & Co$6.28M2.91%0.00%-4.4%Q4 2021
VRDNViridian Therapeutics, Inc.\DE$4.51M2.09%0.14%+24.4%Q4 2024
CPRXCatalyst Pharmaceuticals, Inc.$4.41M2.04%0.15%Not reportedQ4 2023
COGTCogent Biosciences, Inc.$3.62M1.68%0.06%Not reportedQ1 2025
RCUSArcus Biosciences, Inc.$2.89M1.34%0.10%+27.4%Q1 2025
ALKSAlkermes plc.$2.66M1.23%0.06%+392.2%Q2 2023
DCGODocGo Inc.$2.34M1.09%2.71%-13.0%Q4 2021
HELPCybin Inc.$2.33M1.08%1.32%+103.4%Q4 2024
CYTKCytokinetics Inc$2.16M1.00%0.03%+13.3%Q1 2024
ATRCAtriCure, Inc.$2.03M0.94%0.10%+7.1%Q1 2025
ABAlliancebernstein Holding L.P.$1.85M0.86%0.05%Not reportedQ4 2021
ACLXArcellx, Inc.$1.68M0.78%0.04%Not reportedQ1 2023
TECXTectonic Therapeutic, Inc.$1.54M0.71%0.39%Not reportedQ1 2025
WVEWave Life Sciences, Inc.$1.53M0.71%0.05%Not reportedQ1 2025
JNJJohnson & Johnson$1.43M0.66%0.00%Not reportedQ4 2021
TGTXTG Therapeutics, Inc.$1.34M0.62%0.03%Not reportedQ4 2021
VERAVera Therapeutics, Inc.$1.32M0.61%0.04%Not reportedQ1 2025
BHVNBiohaven Ltd.$1.25M0.58%0.08%Not reportedQ1 2022
BMYBristol Myers Squibb Co$1.19M0.55%0.00%-18.5%Q4 2021
MDGLMadrigal Pharmaceuticals, Inc.$1.16M0.54%0.01%Not reportedQ3 2022
ADMAAdma Biologics, Inc.$1.1M0.51%0.03%Not reportedQ4 2021
BIIBBiogen Inc.$1.06M0.49%0.00%+200.0%Q3 2025
OBIOOrchestra BioMed Holdings, Inc.$1.04M0.48%0.44%+28.2%Q2 2025
SLDBSolid Biosciences Inc.$916K0.42%0.21%Not reportedQ1 2025
LENZLENZ Therapeutics, Inc.$860K0.40%0.17%-34.5%Q2 2025
PFEPfizer Inc$805K0.37%0.00%-56.6%Q4 2021
RZLTRezolute, Inc.$802K0.37%0.36%+23.6%Q3 2025
MSFTMicrosoft Corp$774K0.36%0.00%Not reportedQ4 2021
AAPLApple Inc.$678K0.31%0.00%Not reportedQ4 2021
EOLSEvolus, Inc.$661K0.31%0.15%Not reportedQ1 2023
NKTRNektar Therapeutics$655K0.30%0.08%NewQ4 2025
IBMInternational Business Machines Corp$634K0.29%0.00%Not reportedQ1 2023
SRRKScholar Rock Holding Corp$613K0.28%0.01%+54.6%Q3 2025
PTHSPelthos Therapeutics Inc.$598K0.28%0.60%+215.5%Q3 2025
CNQCANADIAN NATURAL RESOURCES Ltd$569K0.26%0.00%Not reportedQ4 2021
CNTBConnect Biopharma Holdings Ltd$564K0.26%0.35%NewQ4 2025
XENEXenon Pharmaceuticals Inc.$491K0.23%0.01%Not reportedQ4 2021
AGIOAgios Pharmaceuticals, Inc.$490K0.23%0.03%NewQ4 2025
RAREUltragenyx Pharmaceutical Inc.$460K0.21%0.02%-61.5%Q1 2025
MRSNMersana Therapeutics, Inc.$438K0.20%2.23%NewQ4 2025
KURAKura Oncology, Inc.$407K0.19%0.04%-41.7%Q2 2024
FATEFate Therapeutics Inc$359K0.17%0.32%Not reportedQ3 2025
Q3 2025Reported Nov 12, 202582 positions
CLMTCalumet, Inc.$51.6M20.79%3.26%-13.7%Q4 2021
APOApollo Global Management, Inc.$30M12.09%0.04%Not reportedQ4 2021
GOOGAlphabet Inc.$27.3M11.02%Not reportedNot reportedQ4 2021
XERSXeris Biopharma Holdings, Inc.$8.26M3.33%0.61%-4.3%Q4 2023
SNDXSyndax Pharmaceuticals Inc$6.58M2.66%0.49%+21.3%Q1 2024
JPMJPMorgan Chase & Co$6.43M2.59%0.00%-2.9%Q4 2021
TVTXTravere Therapeutics, Inc.$6.21M2.51%0.29%Not reportedQ3 2023
AVDLAvadel Pharmaceuticals PLC$5.54M2.24%0.37%-14.8%Q4 2021
PTGXProtagonist Therapeutics, Inc$5.51M2.22%0.13%+3.8%Q3 2023
BBIOBridgeBio Pharma, Inc.$4.41M1.78%0.04%+6.3%Q1 2022
DCGODocGo Inc.$4.18M1.68%3.14%Not reportedQ4 2021
VRNAVerona Pharma plc$4.09M1.65%0.01%-30.3%Q4 2023
LENZLENZ Therapeutics, Inc.$3.82M1.54%0.29%Not reportedQ2 2025
CPRXCatalyst Pharmaceuticals, Inc.$3.72M1.50%0.15%+7.4%Q4 2023
RZLTRezolute, Inc.$2.59M1.04%0.30%NewQ3 2025
VRDNViridian Therapeutics, Inc.\DE$2.52M1.01%0.14%+27.4%Q4 2024
CSXCSX Corp$2.48M1.00%0.00%Not reportedQ1 2023
LQDALiquidia Corp$2.45M0.99%0.12%+19.8%Q4 2021
ACLXArcellx, Inc.$2.11M0.85%0.04%Not reportedQ1 2023
PFEPfizer Inc$1.9M0.77%0.00%Not reportedQ4 2021
ABAlliancebernstein Holding L.P.$1.83M0.74%0.05%Not reportedQ4 2021
ATRCAtriCure, Inc.$1.69M0.68%0.10%+3.4%Q1 2025
CYTKCytokinetics Inc$1.65M0.66%0.03%Not reportedQ1 2024
RAREUltragenyx Pharmaceutical Inc.$1.56M0.63%0.05%Not reportedQ1 2025
PRAXPraxis Precision Medicines, Inc.$1.48M0.60%0.13%NewQ3 2025
RCUSArcus Biosciences, Inc.$1.29M0.52%0.09%+36.0%Q1 2025
JNJJohnson & Johnson$1.28M0.52%0.00%Not reportedQ4 2021
BMYBristol Myers Squibb Co$1.22M0.49%0.00%Not reportedQ4 2021
ABBVAbbVie Inc.$1.17M0.47%0.00%Not reportedQ4 2021
TECXTectonic Therapeutic, Inc.$1.16M0.47%0.40%Not reportedQ1 2025
RHPRyman Hospitality Properties, Inc.$1.08M0.43%0.02%Not reportedQ4 2021
SLDBSolid Biosciences Inc.$1M0.40%0.21%Not reportedQ1 2025
DAWNDay One Biopharmaceuticals, Inc.$920K0.37%0.13%+287.1%Q2 2025
MDGLMadrigal Pharmaceuticals, Inc.$917K0.37%0.01%Not reportedQ3 2022
MSFTMicrosoft Corp$829K0.33%0.00%Not reportedQ4 2021
HELPCybin Inc.$826K0.33%0.65%+109.7%Q4 2024
VERAVera Therapeutics, Inc.$756K0.30%0.04%+30.0%Q1 2025
CTVACorteva, Inc.$747K0.30%0.00%Not reportedQ4 2021
KMBKimberly Clark Corp$746K0.30%0.00%Not reportedQ4 2021
DDDuPont de Nemours, Inc.$734K0.30%0.00%Not reportedQ4 2021
WVEWave Life Sciences, Inc.$659K0.27%0.06%+125.0%Q1 2025
AAPLApple Inc.$635K0.26%0.00%Not reportedQ4 2021
MREOMereo BioPharma Group plc$619K0.25%0.04%-6.0%Q1 2024
IBMInternational Business Machines Corp$604K0.24%0.00%Not reportedQ1 2023
KURAKura Oncology, Inc.$596K0.24%0.08%Not reportedQ2 2024
ALKSAlkermes plc.$579K0.23%0.01%-60.6%Q2 2023
CNQCANADIAN NATURAL RESOURCES Ltd$537K0.22%0.00%Not reportedQ4 2021
MDLZMondelez International, Inc.$500K0.20%0.00%Not reportedQ4 2021
OBIOOrchestra BioMed Holdings, Inc.$484K0.20%0.35%+95.0%Q2 2025
FATEFate Therapeutics Inc$460K0.19%0.32%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.